Apogee Therapeutics, Inc. APGE 深 滬
等待開盤 03-26 09:30:00 美东时间
78.53
+5.530
+7.58%
華盛通- 最 高85.04
- 今 開74.59
- 成交量 353.31万股
- 最 低 73.98
- 昨 收 73.00
- 總市值 54.57亿
- 52周最高 85.04
- 市盈率 靜 --
- 換手率 5.08%
- 52周最低 26.20
- 委 比 0.50%
- 總股本 6948.52万
- 歷史最高 85.04
- 量 比 1.81
- 振 幅 15.15%
- 歷史最低 14.19
- 每 手 1
- 風險率 16.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
Guggenheim Maintains Buy on Apogee Therapeutics, Raises Price Target to $160
Guggenheim analyst Seamus Fernandez maintains Apogee Therapeutics (NASDAQ:APGE) with a Buy and raises the price target from $130 to $160.
03-24 19:32
美股牛股 | 太空概念Satellogic单日暴涨38%！日本在线支付商PayPay上市累涨超50%
太空概念Satellogic单日暴涨38%！将于今日举办NASA供应商研讨会；日本在线支付商PayPay隔夜再升21%，上市累涨超50%>>
03-24 18:51
Apogee Announces $300M Stock Offering
In addition, Apogee expects to grant the underwriters a 30-day option to purchase up to an additional $45 million of shares of its common stock at the public offering price, less underwriting discounts and commissions.
03-24 04:02
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Wall Street analysts have changed their outlook on top names, with new coverage and price targets. See the latest analyst ratings and opinions.
03-18 20:00
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
BTIG Reiterates Buy on Apogee Therapeutics, Maintains $137 Price Target
BTIG analyst Julian Harrison reiterates Apogee Therapeutics (NASDAQ:APGE) with a Buy and maintains $137 price target.
03-16 18:35
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
Wedbush Maintains Outperform on Apogee Therapeutics, Raises Price Target to $95
Wedbush analyst David Nierengarten maintains Apogee Therapeutics (NASDAQ:APGE) with a Outperform and raises the price target from $90 to $95.
03-03 23:03
